Literature DB >> 11724741

Effects of sepsis on mast cells in rat dura mater: influence of L-NAME and VIP.

F Tore1, A M Reynier-Rebuffel, N Tuncel, J Callebert, P Aubineau.   

Abstract

1. The influence of lipopolysaccharide (LPS)-induced sepsis on the various mast cell phenotypes of rat dura mater were examined both by immunohistochemical and biochemical methods. 2. Three different populations of mast cells were identified in control rats: connective tissue type mast cells (CTMC) which contain rat mast cell protease1 (RMCP1), histamine, serotonin and heparin, mucosal type mast cells (MMC) which contain RMCP2, histamine and serotonin, and intermediate type which contains both RMCP1 and RMCP2 and probably various proportions of amines and heparin. 3. LPS (25 mg kg(-1) i.p.) caused changes in the proportions of the various types of mast cells. The number of MMC and intermediate type mast cells significantly increased and the number of mast cells immunopositive for both heparin and serotonin significantly decreased. Biochemical analysis showed that the histamine concentration of dura increased while its serotonin concentration decreased. 4. While vasoactive intestinal peptide (VIP) (25 ng kg(-1) i.p.) appears to potentiate LPS effects on dura mater mast cells, non-selective inhibition of nitric oxide (NO) synthase by N(g)-nitro-L-arginine methyl ester (L-NAME) (30 mg kg(-1) i.p.) did not influence sepsis-induced mast cell changes. 5. These findings suggest that mast cells of dura mater may play a role in brain protection during sepsis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724741      PMCID: PMC1573094          DOI: 10.1038/sj.bjp.0704412

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock.

Authors:  N Tunçel; F Töre; V Sahintürk; D Ak; M Tunçel
Journal:  Peptides       Date:  2000-01       Impact factor: 3.750

2.  Linear arrays of homogeneous mast cells in the dura mater of the rat.

Authors:  R V Dimlich; J T Keller; T A Strauss; M J Fritts
Journal:  J Neurocytol       Date:  1991-06

3.  Mast cell degranulation in hemorrhagic shock in rats and the effects of vasoactive intestinal peptide, aprotinin and H1 and H2-receptor blockers on degranulation.

Authors:  H Tikiz; N Tunçel; F Gürer; C Baycu
Journal:  Pharmacology       Date:  1991       Impact factor: 2.547

4.  Vasoactive intestinal peptide in sepsis and shock.

Authors:  A Revhaug; I Lygren; T G Jenssen; K E Giercksky; P G Burhol
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  Mast cells in rat gastrointestinal mucosa. I. Effects of fixation.

Authors:  L Enerbäck
Journal:  Acta Pathol Microbiol Scand       Date:  1966

6.  Elevated VIP and endotoxin plasma levels in human gram-negative septic shock.

Authors:  P Brandtzaeg; O Oktedalen; P Kierulf; P K Opstad
Journal:  Regul Pept       Date:  1989-01

7.  Rat mast cells inhibit platelet aggregation by releasing a nitric oxide-like factor: influence of histamine release.

Authors:  P F Mannaioni; E Masini; A Pistelli; D Salvemini; J R Vane
Journal:  Agents Actions Suppl       Date:  1991

Review 8.  Nitric oxide and intestinal inflammation.

Authors:  P Kubes; D M McCafferty
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

9.  Cluster headache: ultrastructural evidence for mast cell degranulation and interaction with nerve fibres in the human temporal artery.

Authors:  V Dimitriadou; P Henry; B Brochet; P Mathiau; P Aubineau
Journal:  Cephalalgia       Date:  1990-10       Impact factor: 6.292

10.  Simultaneous determination of histamine and N alpha-methylhistamine in biological samples by an improved enzymatic single isotope assay.

Authors:  M Haimart; J M Launay; G Zürcher; N Cauet; C Dreux; M Da Prada
Journal:  Agents Actions       Date:  1985-04
View more
  8 in total

1.  Mast cells in the human dura: effects of age and dural bleeding.

Authors:  A Varatharaj; J Mack; J R Davidson; A Gutnikov; W Squier
Journal:  Childs Nerv Syst       Date:  2012-01-22       Impact factor: 1.475

2.  Developmental changes of mast cell populations in the cerebral meninges of the rat.

Authors:  Helen Michaloudi; Christos Batzios; Maria Chiotelli; Georgios C Papadopoulos
Journal:  J Anat       Date:  2007-09-06       Impact factor: 2.610

3.  A chronic scheme of cranial window preparation to study pial vascular reactivity in murine cerebral malaria.

Authors:  Peng Kai Ong; Diana Meays; John A Frangos; Leonardo J M Carvalho
Journal:  Microcirculation       Date:  2013-07       Impact factor: 2.628

4.  Dural Cells Release Factors Which Promote Cancer Cell Malignancy and Induce Immunosuppressive Markers in Bone Marrow Myeloid Cells.

Authors:  Nicholas J Szerlip; Alexandra Calinescu; Eleanor Smith; Rebecca Tagett; Katrina L Clines; Henry H Moon; Russell S Taichman; Catherine H Van Poznak; Gregory A Clines
Journal:  Neurosurgery       Date:  2018-12-01       Impact factor: 4.654

5.  The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats.

Authors:  Fatma Tore; Orhan Tansel Korkmaz; Dilek Dogrukol-Ak; Nese Tunçel
Journal:  J Mol Neurosci       Date:  2009-11-20       Impact factor: 3.444

Review 6.  The Influence of Early Life Experience on Visceral Pain.

Authors:  Isabella M Fuentes; Julie A Christianson
Journal:  Front Syst Neurosci       Date:  2018-01-26

7.  Bovine Intestinal Alkaline Phosphatase Reduces Inflammation After Induction of Acute Myocardial Infarction in Mice.

Authors:  Danielle Fiechter; Suzanne Kats; Ruud Brands; Ben van Middelaar; Gerard Pasterkamp; Dominique de Kleijn; Willem Seinen
Journal:  Cardiol Res       Date:  2011-09-20

Review 8.  Thirst sensation and oral dryness following alcohol intake.

Authors:  Kiyotoshi Inenaga; Kentaro Ono; Suzuro Hitomi; Ayu Kuroki; Izumi Ujihara
Journal:  Jpn Dent Sci Rev       Date:  2017-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.